Skip to main content
. 2017 Aug 17;12:2445–2454. doi: 10.2147/COPD.S141409

Figure 2.

Figure 2

Comparison of outcomes between pMDI and DPI, in the 1,000 μg/d cohort.

Notes: *RR adjusted for number of baseline moderate/severe COPD exacerbations; OR adjusted for baseline LAMA prescription (yes/no); unadjusted OR.

Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; DPI, dry powder inhaler; LAMA, long-acting muscarinic agonists; MDI, metered-dose inhaler; OR, odds ratio; pMDI, pressurized metered-dose inhaler; RR, rate ratio.